Premium
Phenotypic spectrum associated with de novo mutations in QRICH1 gene
Author(s) -
Ververi A.,
Splitt M.,
Dean J. C. S.,
Brady A. F.
Publication year - 2018
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.13096
Subject(s) - phenotype , genetics , exome sequencing , biology , gene , loss function , mutation
Rare de novo mutations represent a significant cause of idiopathic developmental delay (DD). The use of next‐generation sequencing ( NGS ) has boosted the identification of de novo mutations in an increasing number of novel genes. Here we present 3 unrelated children with de novo loss‐of‐function ( LoF ) mutations in QRICH1 , diagnosed through trio‐based exome sequencing. QRICH1 encodes the glutamine‐rich protein 1, which contains 1 caspase activation recruitment domain and is likely to be involved in apoptosis and inflammation. All 3 children had speech delay, learning difficulties, a prominent nose and a thin upper lip. In addition, 2 of them had mildly raised creatine kinase ( CK ) and 1 of them had autism. Despite their small number, the patients had a relatively consistent pattern of clinical features suggesting the presence of a QRICH1 ‐associated phenotype. LoF mutations in QRICH1 are suggested as a novel cause of DD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom